Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 189

1.

Follow up after sample size re-estimation in a breast cancer randomized trial for disease-free survival.

Hade EM, Young GS, Love RR.

Trials. 2019 Aug 23;20(1):527. doi: 10.1186/s13063-019-3632-9.

2.

In Silico Karyotyping of Chromosomally Polymorphic Malaria Mosquitoes in the Anopheles gambiae Complex.

Love RR, Redmond SN, Pombi M, Caputo B, Petrarca V, Torre AD, Consortium TAGTG, Besansky NJ.

G3 (Bethesda). 2019 Aug 7. pii: g3.400445.2019. doi: 10.1534/g3.119.400445. [Epub ahead of print]

3.

SmartHeLP: Smartphone-based Hemoglobin Level Prediction Using an Artificial Neural Network.

Hasan MK, Haque MM, Adib R, Tumpa JF, Begum A, Love RR, Kim YL, Sheikh IA.

AMIA Annu Symp Proc. 2018 Dec 5;2018:535-544. eCollection 2018.

4.

Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.

Love RR.

N Engl J Med. 2018 Oct 25;379(17):1683. doi: 10.1056/NEJMc1810514. No abstract available.

PMID:
30358970
5.

Symptoms In Bangladeshi Patients with Incurable Cancers: Implications for Interventions.

Love RR, Tanimul Ahsan GM, Ferdousy T, Nahar S, Ahamed SI.

Indian J Palliat Care. 2018 Apr-Jun;24(2):173-175. doi: 10.4103/IJPC.IJPC_203_17.

6.

20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.

Pan H, Gray R, Braybrooke J, Davies C, Taylor C, McGale P, Peto R, Pritchard KI, Bergh J, Dowsett M, Hayes DF; EBCTCG.

N Engl J Med. 2017 Nov 9;377(19):1836-1846. doi: 10.1056/NEJMoa1701830.

7.

Symptom Levels in Care-Seeking Bangladeshi and Nepalese Adults With Advanced Cancer.

Love RR, Ferdousy T, Paudel BD, Nahar S, Dowla R, Adibuzzaman M, Ahsan GMT, Uddin M, Salim R, Ahamed SI.

J Glob Oncol. 2016 Jul 27;3(3):257-260. doi: 10.1200/JGO.2016.004119. eCollection 2017 Jun.

8.

Serum Metabolomic Profiles Identify ER-Positive Early Breast Cancer Patients at Increased Risk of Disease Recurrence in a Multicenter Population.

Hart CD, Vignoli A, Tenori L, Uy GL, Van To T, Adebamowo C, Hossain SM, Biganzoli L, Risi E, Love RR, Luchinat C, Di Leo A.

Clin Cancer Res. 2017 Mar 15;23(6):1422-1431. doi: 10.1158/1078-0432.CCR-16-1153. Epub 2017 Jan 12.

9.

Chromosomal inversions and ecotypic differentiation in Anopheles gambiae: the perspective from whole-genome sequencing.

Love RR, Steele AM, Coulibaly MB, Traore SF, Emrich SJ, Fontaine MC, Besansky NJ.

Mol Ecol. 2016 Dec;25(23):5889-5906. doi: 10.1111/mec.13888. Epub 2016 Nov 9.

10.

On the road to precision, there is more practical medicine to be implemented.

Love RR.

Breast. 2016 Oct;29:188-91. doi: 10.1016/j.breast.2016.06.003. Epub 2016 Jun 18.

PMID:
27329865
11.

Adjuvant Surgical Oophorectomy Plus Tamoxifen in Premenopausal Women With Operable Hormone Receptor-Positive Breast Cancer: A Global Treatment Option.

Love RR.

Clin Breast Cancer. 2016 Aug;16(4):233-7. doi: 10.1016/j.clbc.2016.03.003. Epub 2016 Mar 31. Review.

PMID:
27117241
12.

Luteal versus follicular phase surgical oophorectomy plus tamoxifen in premenopausal women with metastatic hormone receptor-positive breast cancer.

Love RR, Hossain SM, Hussain MM, Mostafa MG, Laudico AV, Siguan SS, Adebamowo C, Sun JZ, Fei F, Shao ZM, Liu Y, Akram Hussain SM, Zhang B, Cheng L, Panigaro S, Walta F, Chuan JH, Mirasol-Lumague MR, Yip CH, Navarro NS Jr, Huang CS, Lu YS, Ferdousy T, Salim R, Akhter C, Nahar S, Uy G, Young GS, Hade EM, Jarjoura D.

Eur J Cancer. 2016 Jun;60:107-16. doi: 10.1016/j.ejca.2016.03.011. Epub 2016 Apr 20.

13.

Peri-operative biology in primary breast cancer: a credible therapeutic target.

Love RR, Love SM.

Breast Cancer Res Treat. 2016 Apr;156(3):411-413. doi: 10.1007/s10549-016-3762-7. Epub 2016 Mar 24. Review.

PMID:
27013472
14.

Evaluation of DISCOVAR de novo using a mosquito sample for cost-effective short-read genome assembly.

Love RR, Weisenfeld NI, Jaffe DB, Besansky NJ, Neafsey DE.

BMC Genomics. 2016 Mar 5;17:187. doi: 10.1186/s12864-016-2531-7.

15.

Feasibility Study of Case-Finding for Breast Cancer by Community Health Workers in Rural Bangladesh.

Chowdhury TI, Love RR, Chowdhury MT, Artif AS, Ahsan H, Mamun A, Khanam T, Woods J, Salim R.

Asian Pac J Cancer Prev. 2015;16(17):7853-7.

16.

Timing of adjuvant surgical oophorectomy in the menstrual cycle and disease-free and overall survival in premenopausal women with operable breast cancer.

Love RR, Laudico AV, Van Dinh N, Allred DC, Uy GB, Quang le H, Salvador JD, Siguan SS, Mirasol-Lumague MR, Tung ND, Benjaafar N, Navarro NS Jr, Quy TT, De La Peña AS, Dofitas RB, Bisquera OC Jr, Linh ND, To TV, Young GS, Hade EM, Jarjoura D.

J Natl Cancer Inst. 2015 Mar 19;107(6):djv064. doi: 10.1093/jnci/djv064. Print 2015 Jun.

17.

The international cancer expert corps: a unique approach for sustainable cancer care in low and lower-middle income countries.

Coleman CN, Formenti SC, Williams TR, Petereit DG, Soo KC, Wong J, Chao N, Shulman LN, Grover S, Magrath I, Hahn S, Liu FF, DeWeese T, Khleif SN, Steinberg M, Roth L, Pistenmaa DA, Love RR, Mohiuddin M, Vikram B.

Front Oncol. 2014 Nov 19;4:333. doi: 10.3389/fonc.2014.00333. eCollection 2014. Review.

18.

Mosquito genomics. Extensive introgression in a malaria vector species complex revealed by phylogenomics.

Fontaine MC, Pease JB, Steele A, Waterhouse RM, Neafsey DE, Sharakhov IV, Jiang X, Hall AB, Catteruccia F, Kakani E, Mitchell SN, Wu YC, Smith HA, Love RR, Lawniczak MK, Slotman MA, Emrich SJ, Hahn MW, Besansky NJ.

Science. 2015 Jan 2;347(6217):1258524. doi: 10.1126/science.1258524. Epub 2014 Nov 27.

19.

Transforming science, service, and society.

Coleman CN, Love RR.

Sci Transl Med. 2014 Oct 22;6(259):259fs42. doi: 10.1126/scitranslmed.3009640.

PMID:
25338753
20.

Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.

EBCTCG (Early Breast Cancer Trialists' Collaborative Group), McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, Gray R, Mannu G, Peto R, Whelan T, Wang Y, Wang Z, Darby S.

Lancet. 2014 Jun 21;383(9935):2127-35. doi: 10.1016/S0140-6736(14)60488-8. Epub 2014 Mar 19. Erratum in: Lancet. 2014 Nov 22;384(9957):1848.

21.

Bone mineral density following surgical oophorectomy and tamoxifen adjuvant therapy for breast cancer.

Love RR, Young GS, Laudico AV, Van Dinh N, Uy GB, Quang le H, De La Peña AS, Dofitas RB, Bisquera OC Jr, Siguan SS, Salvador JD, Mirasol-Lumague MR, Navarro NS Jr, Linh ND, Jarjoura D.

Cancer. 2013 Nov 1;119(21):3746-52. doi: 10.1002/cncr.28302. Epub 2013 Aug 20.

22.

CYP2D6 genotypes, endoxifen levels, and disease recurrence in 224 Filipino and Vietnamese women receiving adjuvant tamoxifen for operable breast cancer.

Love RR, Desta Z, Flockhart D, Skaar T, Ogburn ET, Ramamoorthy A, Uy GB, Laudico AV, Van Dinh N, Quang le H, Van To T, Young GS, Hade E, Jarjoura D.

Springerplus. 2013 Dec;2(1):52. doi: 10.1186/2193-1801-2-52. Epub 2013 Feb 15.

23.

Public health oncology: a framework for progress in low- and middle-income countries.

Love RR, Ginsburg OM, Coleman CN.

Ann Oncol. 2012 Dec;23(12):3040-5. doi: 10.1093/annonc/mds473. Epub 2012 Oct 19.

24.

Improving outcomes from breast cancer in a low-income country: lessons from bangladesh.

Story HL, Love RR, Salim R, Roberto AJ, Krieger JL, Ginsburg OM.

Int J Breast Cancer. 2012;2012:423562. doi: 10.1155/2012/423562. Epub 2011 Dec 5.

25.

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, Cutter D, Davies C, Ewertz M, Godwin J, Gray R, Pierce L, Whelan T, Wang Y, Peto R.

Lancet. 2011 Nov 12;378(9804):1707-16. doi: 10.1016/S0140-6736(11)61629-2. Epub 2011 Oct 19. Review.

26.

Cytoplasmic estrogen receptor in breast cancer.

Welsh AW, Lannin DR, Young GS, Sherman ME, Figueroa JD, Henry NL, Ryden L, Kim C, Love RR, Schiff R, Rimm DL.

Clin Cancer Res. 2012 Jan 1;18(1):118-26. doi: 10.1158/1078-0432.CCR-11-1236. Epub 2011 Oct 6.

27.

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Davies C, Godwin J, Gray R, Clarke M, Cutter D, Darby S, McGale P, Pan HC, Taylor C, Wang YC, Dowsett M, Ingle J, Peto R.

Lancet. 2011 Aug 27;378(9793):771-84. doi: 10.1016/S0140-6736(11)60993-8. Epub 2011 Jul 28.

28.

Breast cancer: a neglected disease for the majority of affected women worldwide.

Ginsburg OM, Love RR.

Breast J. 2011 May-Jun;17(3):289-95. doi: 10.1111/j.1524-4741.2011.01067.x. Epub 2011 Mar 16.

29.

Effects on survival of menstrual cycle phase of adjuvant surgical oophorectomy in premenopausal women with breast cancer.

Love RR, Young GS, Hade EM, Jarjoura D.

Breast Cancer Res Treat. 2011 Apr;126(2):479-85. doi: 10.1007/s10549-011-1370-0. Epub 2011 Feb 4.

PMID:
21293921
30.

Global cancer research initiative.

Love RR.

Cancer Manag Res. 2010 May 3;2:105-9.

31.

Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Correa C, McGale P, Taylor C, Wang Y, Clarke M, Davies C, Peto R, Bijker N, Solin L, Darby S.

J Natl Cancer Inst Monogr. 2010;2010(41):162-77. doi: 10.1093/jncimonographs/lgq039. Review.

32.

Family history, BRCA mutations and breast cancer in Vietnamese women.

Ginsburg OM, Dinh NV, To TV, Quang LH, Linh ND, Duong BT, Royer R, Llacuachaqui M, Tulman A, Vichodez G, Li S, Love RR, Narod SA.

Clin Genet. 2011 Jul;80(1):89-92. doi: 10.1111/j.1399-0004.2010.01545.x. Epub 2010 Oct 18.

PMID:
20950396
33.
34.

Breast cancer hormone receptor assay results of core needle biopsy and modified radical mastectomy specimens from the same patients.

Uy GB, Laudico AV, Carnate JM Jr, Lim FG, Fernandez AM, Rivera RR, Mapua CA, Love RR.

Clin Breast Cancer. 2010 Apr;10(2):154-9. doi: 10.3816/CBC.2010.n.021.

35.
36.

Surgical oophorectomy for breast cancer: back to the future.

Love RR, Uy GB.

Future Oncol. 2008 Dec;4(6):785-92. doi: 10.2217/14796694.4.6.785. Review.

PMID:
19086845
37.

Defining a global research agenda for breast cancer.

Love RR.

Cancer. 2008 Oct 15;113(8 Suppl):2366-71. doi: 10.1002/cncr.23831.

38.

Guideline implementation for breast healthcare in low- and middle-income countries: treatment resource allocation.

Eniu A, Carlson RW, El Saghir NS, Bines J, Bese NS, Vorobiof D, Masetti R, Anderson BO; Breast Health Global Initiative Treatment Panel.

Cancer. 2008 Oct 15;113(8 Suppl):2269-81. doi: 10.1002/cncr.23843.

39.

Survival after adjuvant oophorectomy and tamoxifen in operable breast cancer in premenopausal women.

Love RR, Van Dinh N, Quy TT, Linh ND, Tung ND, Shen TZ, Hade EM, Young GS, Jarjoura D.

J Clin Oncol. 2008 Jan 10;26(2):253-7. Epub 2007 Dec 17.

PMID:
18086800
40.

Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer.

Bailey HH, Attia S, Love RR, Fass T, Chappell R, Tutsch K, Harris L, Jumonville A, Hansen R, Shapiro GR, Stewart JA.

Cancer Chemother Pharmacol. 2008 Jun;62(1):149-57. Epub 2007 Sep 21.

PMID:
17885756
41.

Broadening our perspective on breast cancer.

Love RR.

Oncology (Williston Park). 2007 Apr;21(4):524; author reply 524-5. No abstract available.

42.

What causes cancer? Reports from sixth-grade girls.

Nichols HB, Trentham-Dietz A, Newcomb PA, Yanke L, Remington PL, Love RR.

J Cancer Educ. 2006 Fall;21(3):142-6.

PMID:
17371178
43.

'Repairing the world'--oncologists needed for foreign service.

Love RR.

Oncology (Williston Park). 2007 Jan;21(1):130. No abstract available.

44.

Population health, global bioethics and breast cancer treatment.

Love RR.

Oncology (Williston Park). 2006 Jun;20(7):675. No abstract available.

45.

Breast cancer in limited-resource countries: treatment and allocation of resources.

Eniu A, Carlson RW, Aziz Z, Bines J, Hortobágyi GN, Bese NS, Love RR, Vikram B, Kurkure A, Anderson BO; Global Summit Treatment and Allocation of Resources Panel.

Breast J. 2006 Jan-Feb;12 Suppl 1:S38-53.

PMID:
16430398
46.

Effect of exemestane on tamoxifen pharmacokinetics in postmenopausal women treated for breast cancer.

Hutson PR, Love RR, Havighurst TC, Rogers E, Cleary JF.

Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8722-7.

47.

Correlates of age at menarche among sixth grade students in Wisconsin.

Trentham-Dietz A, Nichols HB, Remington PL, Yanke L, Hampton JM, Newcomb PA, Love RR.

WMJ. 2005 Sep;104(7):65-9.

48.

Endocrine effects of tamoxifen plus exemestane in postmenopausal women with breast cancer.

Love RR, Hutson PR, Havighurst TC, Cleary JF.

Clin Cancer Res. 2005 Feb 15;11(4):1500-3.

49.

Differences in breast cancer risk factors by tumor marker subtypes among premenopausal Vietnamese and Chinese women.

Nichols HB, Trentham-Dietz A, Love RR, Hampton JM, Hoang Anh PT, Allred DC, Mohsin SK, Newcomb PA.

Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):41-7.

50.

Models of breast cancer growth and investigations of adjuvant surgical oophorectomy.

Love RR, Niederhuber JE.

Ann Surg Oncol. 2004 Sep;11(9):818-28. Review.

PMID:
15342347

Supplemental Content

Loading ...
Support Center